181 related articles for article (PubMed ID: 11728339)
1. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein.
Boackle SA; Holers VM; Chen X; Szakonyi G; Karp DR; Wakeland EK; Morel L
Immunity; 2001 Nov; 15(5):775-85. PubMed ID: 11728339
[TBL] [Abstract][Full Text] [Related]
2. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c.
Chen Y; Perry D; Boackle SA; Sobel ES; Molina H; Croker BP; Morel L
J Immunol; 2005 Jul; 175(2):1080-9. PubMed ID: 16002709
[TBL] [Abstract][Full Text] [Related]
3. An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.
Tchepeleva SN; Thurman JM; Ruff K; Perkins SJ; Morel L; Boackle SA
J Immunol; 2010 Aug; 185(4):2331-9. PubMed ID: 20660348
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of NZB autoimmune phenotypes by the Sle1c murine lupus susceptibility interval.
Giles BM; Tchepeleva SN; Kachinski JJ; Ruff K; Croker BP; Morel L; Boackle SA
J Immunol; 2007 Apr; 178(7):4667-75. PubMed ID: 17372026
[TBL] [Abstract][Full Text] [Related]
5. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus.
Wu H; Boackle SA; Hanvivadhanakul P; Ulgiati D; Grossman JM; Lee Y; Shen N; Abraham LJ; Mercer TR; Park E; Hebert LA; Rovin BH; Birmingham DJ; Chang DM; Chen CJ; McCurdy D; Badsha HM; Thong BY; Chng HH; Arnett FC; Wallace DJ; Yu CY; Hahn BH; Cantor RM; Tsao BP
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3961-6. PubMed ID: 17360460
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional effects of a lupus-associated polymorphism in the 5' untranslated region (UTR) of human complement receptor 2 (CR2/CD21).
Cruickshank MN; Karimi M; Mason RL; Fenwick E; Mercer T; Tsao BP; Boackle SA; Ulgiati D
Mol Immunol; 2012 Oct; 52(3-4):165-73. PubMed ID: 22673213
[TBL] [Abstract][Full Text] [Related]
7. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.
Zhao J; Giles BM; Taylor RL; Yette GA; Lough KM; Ng HL; Abraham LJ; Wu H; Kelly JA; Glenn SB; Adler AJ; Williams AH; Comeau ME; Ziegler JT; Marion M; Alarcón-Riquelme ME; ; Alarcón GS; Anaya JM; Bae SC; Kim D; Lee HS; Criswell LA; Freedman BI; Gilkeson GS; Guthridge JM; Jacob CO; James JA; Kamen DL; Merrill JT; Sivils KM; Niewold TB; Petri MA; Ramsey-Goldman R; Reveille JD; Scofield RH; Stevens AM; Vilá LM; Vyse TJ; Kaufman KM; Harley JB; Langefeld CD; Gaffney PM; Brown EE; Edberg JC; Kimberly RP; Ulgiati D; Tsao BP; Boackle SA
Ann Rheum Dis; 2016 Jan; 75(1):242-52. PubMed ID: 25180293
[TBL] [Abstract][Full Text] [Related]
8. Role of complement in the development of autoimmunity.
Boackle SA; Holers VM
Curr Dir Autoimmun; 2003; 6():154-68. PubMed ID: 12408051
[TBL] [Abstract][Full Text] [Related]
9. Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus.
Croker BP; Gilkeson G; Morel L
Genes Immun; 2003 Dec; 4(8):575-85. PubMed ID: 14647198
[TBL] [Abstract][Full Text] [Related]
10. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes.
Morel L; Blenman KR; Croker BP; Wakeland EK
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1787-92. PubMed ID: 11172029
[TBL] [Abstract][Full Text] [Related]
11. Murine lupus susceptibility locus Sle1c2 mediates CD4+ T cell activation and maps to estrogen-related receptor γ.
Perry DJ; Yin Y; Telarico T; Baker HV; Dozmorov I; Perl A; Morel L
J Immunol; 2012 Jul; 189(2):793-803. PubMed ID: 22711888
[TBL] [Abstract][Full Text] [Related]
12. A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus.
Wu X; Jiang N; Deppong C; Singh J; Dolecki G; Mao D; Morel L; Molina HD
J Immunol; 2002 Aug; 169(3):1587-92. PubMed ID: 12133988
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus.
Asokan R; Hua J; Young KA; Gould HJ; Hannan JP; Kraus DM; Szakonyi G; Grundy GJ; Chen XS; Crow MK; Holers VM
J Immunol; 2006 Jul; 177(1):383-94. PubMed ID: 16785534
[TBL] [Abstract][Full Text] [Related]
14. Association of Complement Receptor 2 Gene Polymorphisms with Susceptibility to Osteonecrosis of the Femoral Head in Systemic Lupus Erythematosus.
Kim TH; Bae SC; Lee SH; Kim SY; Baek SH
Biomed Res Int; 2016; 2016():9208035. PubMed ID: 27446959
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus.
Kulik L; Laskowski J; Renner B; Woolaver R; Zhang L; Lyubchenko T; You Z; Thurman JM; Holers VM
J Immunol; 2019 Dec; 203(12):3136-3147. PubMed ID: 31732528
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
17. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing.
Douglas KB; Windels DC; Zhao J; Gadeliya AV; Wu H; Kaufman KM; Harley JB; Merrill J; Kimberly RP; Alarcón GS; Brown EE; Edberg JC; Ramsey-Goldman R; Petri M; Reveille JD; Vilá LM; Gaffney PM; James JA; Moser KL; Alarcón-Riquelme ME; Vyse TJ; Gilkeson GS; Jacob CO; Ziegler JT; Langefeld CD; Ulgiati D; Tsao BP; Boackle SA
Genes Immun; 2009 Jul; 10(5):457-69. PubMed ID: 19387458
[TBL] [Abstract][Full Text] [Related]
18. Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE).
Asokan R; Banda NK; Szakonyi G; Chen XS; Holers VM
Mol Immunol; 2013 Jan; 53(1-2):99-110. PubMed ID: 22885687
[TBL] [Abstract][Full Text] [Related]
19. Genetic determination of T cell help in loss of tolerance to nuclear antigens.
Chen Y; Cuda C; Morel L
J Immunol; 2005 Jun; 174(12):7692-702. PubMed ID: 15944270
[TBL] [Abstract][Full Text] [Related]
20. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
Kazatchkine MD; Fearon DT
Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]